Ruggie Capital Group’s Gilead Sciences GILD Stock Holding History

Ruggie Capital Group’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-15	Closed	-$1K	–	305
2019 Q1	$1K	Hold	15	–	–	﹤0.01%	149
2018 Q4	$1K	Hold	15	–	–	﹤0.01%	459
2018 Q3	$1K	Sell	15 -15	-50%	-$1.13K	﹤0.01%	223
2018 Q2	$2K	Hold	30	–	–	﹤0.01%	301
2018 Q1	$2K	Hold	30	–	–	﹤0.01%	260
2017 Q4	$2K	Hold	30	–	–	﹤0.01%	276
2017 Q3	$2K	Hold	30	–	–	﹤0.01%	222
2017 Q2	$2K	Hold	30	–	–	﹤0.01%	247
2017 Q1	$2K	Hold	30	–	–	﹤0.01%	227
2016 Q4	$2K	Hold	30	–	–	﹤0.01%	134
2016 Q3	$2K	Sell	30 -152	-84%	-$12.3K	﹤0.01%	165
2016 Q2	$15K	Hold	182	–	–	0.01%	143
2016 Q1	$17K	Buy	+182	New	+$16.4K	0.02%	114
2015 Q4	–	Sell	-197	Closed	-$21K	–	65
2015 Q3	$21K	Sell	197 -141	-42%	-$15.7K	0.02%	111
2015 Q2	$40K	Buy	338 +92	+37%	+$10.1K	0.03%	98
2015 Q1	$24K	Buy	246 +36	+17%	+$3.66K	0.03%	100
2014 Q4	$20K	Buy	+210	New	+$21.7K	0.02%	122

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

AAMU

Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ruggie Capital Group's GILD Position: Q2 2019 in Review

Ruggie Capital Group sold out of Gilead Sciences (GILD) in Q2 2019, closing a stake of 15 shares — an estimated $1K sold.

Ruggie Capital Group first reported a position in GILD in Q4 2014 and held it in 17 quarters. The position peaked at $40K in Q2 2015. 1,483 funds tracked by Wall St. Rank hold GILD as of Q2 2019.

Ruggie Capital Group reported no remaining Gilead Sciences position as of Q2 2019 after selling out during the quarter.
Ruggie Capital Group sold 15 Gilead Sciences shares in Q2 2019, an estimated $1K.
Ruggie Capital Group first reported a position in Gilead Sciences in Q4 2014 and held it in 17 quarters.
Ruggie Capital Group's Gilead Sciences position peaked at $40K in Q2 2015.
1,483 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2019.

Based on Ruggie Capital Group's 13F filing for Q2 2019, filed 5 Aug 2019.